By Izzy Wood (Drug Target Review)2023-02-01T13:50:02
Chronic pain often leads to depression, which US researchers have potentially solved using a mechanism involved with ketamine.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-05T13:24:00
Sponsored by HUB Organoids
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
2023-07-04T10:05:58
Sponsored by Revvity
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2024-01-26T13:22:42
Sponsored by bit.bio
Site powered by Webvision Cloud